Tested Applications
| Positive WB detected in | mouse liver tissue, HepG2 cells, mouse lung tissue, mouse spleen tissue |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
31265-1-AP targets Apolipoprotein AI in WB, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Eg0757 Product name: Recombinant Human Apolipoprotein AI protein (His Tag) Source: mammalian cells-derived, pHZ-KIsec-C-6*HIS Tag: C-6*HIS Domain: 25-267 aa of BC005380 Sequence: DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Predict reactive species |
| Full Name | apolipoprotein A-I |
| Calculated Molecular Weight | 31 kDa |
| Observed Molecular Weight | 26 kDa |
| GenBank Accession Number | BC005380 |
| Gene Symbol | APOA1 |
| Gene ID (NCBI) | 335 |
| RRID | AB_3669923 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity Purification |
| UNIPROT ID | P02647 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
ApoA1 is a major protein component of high density lipoproteins (HDL) which is associated with reversed cholesterol transport, lipid/cholesterol binding, lecithin/cholesterol acyltransferase (LCAT) activation and specific receptors binding. It is synthesized in the liver and small intestine. Defects of ApoA1 cause low HDL level and systemic non-neuropathic amyloidosis. Serum concentration of ApoA1 is inversely related to the risk of developing atherosclerosis. This antibody was generated against the C-terminal region of human ApoA1.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Apolipoprotein AI antibody 31265-1-AP | Download protocol |
| WB protocol for Apolipoprotein AI antibody 31265-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Apolipoprotein AI Polyclonal antibody (Cat# 31265-1-AP) has 1 total citation. It was cited in Phytomedicine (IF 11.3), in a 2025 study investigating co-administration of berberine and evodiamine for mitigating hepatotoxicity and potentiating colitis treatment. The associated research fields include phytomedicine, hepatotoxicity, and inflammatory bowel disease. The antibody was used for Western Blot (WB) in this publication.
| Species | Application | Title |
|---|---|---|
Phytomedicine Co-administration of berberine and evodiamine: Mitigating evodiamine-induced hepatotoxicity and potentiating colitis treatment |







